2 min read
ISLAMABAD: Citi Pharma Limited (PSX: CPHL) has successfully completed its first Citi Pharma export to MENA, securing an order worth €560,000. This milestone follows the company’s FDA accreditation announced on September 20, 2024, as per its filing to the stock exchange on Thursday.
Of the total export value, €200,000 was received in advance, while the remaining €360,000 has now been finalized, confirming the completion of the transaction.
CPHL aims to expand its international footprint, projecting annual exports of €8-10 million to the MENA region and a similar value to other international markets, including North America.
This achievement strengthens Citi Pharma export to MENA, according to the filing, enhancing its global market presence and unlocking further growth opportunities. The company specializes in manufacturing and selling pharmaceuticals, medical chemicals, and botanical products.
